Growth

medicine

Worldwide Cancer Molecular Diagnostics Industry to 2025 – Personalized Medicine and Pharmacogenomics are Driving Growth

DUBLIN, Dec. 1, 2020 /PRNewswire/ — The “Molecular Diagnostics for Cancer – Markets, Strategies and Trends. Forecasts by Cancer Type, Including Companion Dx and by Country with Executive and Consultant Guides and COVID-19 Pandemic Recession Forecast Revisions. 2021 to 2025” report has been added to ResearchAndMarkets.com’s offering.

A market with fundamental growth factors is impacted by the COVID-19 Pandemic. Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge but shifting resources to deal with the COVID emergency may interrupt growth. Learn all about it in this new report. the publisher includes a special segment, Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. And now over 130 companies are profiled. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

  • personalized medicine
  • pharmacogenomics
  • liquid biopsy
  • emergence of new economies with large markets
  • greater understanding of the role of genetic material in Disease and Health

Working against this dynamic market are the forces of the COVID Driven Recession. The publisher’s latest numbers factor in the different COVID forces, their timing, and their effect on growth.

Exciting technical developments especially in the area of pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

This report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2020 United States Medicare Fee Payment Schedules to help understand test pricing in detail. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges, please enquire further for more information.

The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

Key Topics Covered:

1. Introduction and Market Definition

2. Market Overview
2.1 Market Participants
2.1.1 Academic Research Lab
2.1.2 Diagnostic Test Developer
2.1.3 Genomic Instrumentation Supplier
2.1.4 Pharmaceutical/Reagent Supplier
2.1.5 Independent Testing Lab
2.1.6 Public National/regional lab
2.1.7 Hospital lab
2.1.8 Physician Lab
2.1.9 Audit Body
2.1.10 Certification Body
2.2 Market Segments
2.2.1 Traditional Market Segmentation
2.2.2 Laboratory Focus and Segmentation
2.3 Industry Structure
2.3.1 Hospital Testing Share
2.3.2 Economies of Scale
2.3.3 Physician Office Lab’s
2.3.4 Physician’s and POCT

3. Market Trends
3.1 Factors Driving Growth
3.1.1 New Diagnostics Create New Markets
3.1.2 New Roles for Diagnostics
3.1.3 Longevity and Outcomes
3.1.3 Expanding the Pharmaceutical Toolbox
3.1.4 Regulatory Retreat
3.2 Factors Limiting Growth
3.2.1 Falling Prices
3.2.2 Lower Costs
3.2.3 COVID Pandemic
3.2.4 Wellness has a Downside
3.3 Instrumentation and Automation
3.3.1 Instruments Key to Market Share
3.3.2 Bioinformatics Plays a Role

Read More
medicine

Pfizer: A ‘New’ Growth Foundation In Genomic Medicine (NYSE:PFE)

Source: Finviz

“With the separation of Consumer Health last year and the expected separation of Upjohn later this year, we are significantly transforming our company. We are evolving from a diversified enterprise to a more focused and innovative biopharma company, from a scientific fast follower to a first-in-class scientific powerhouse. The transformation of this magnitude (began in 2010) could not happen within 1 or 2 years. The increased R&D productivity, as well as the depth and breadth of our pipeline, gave us the confidence to move so quickly over the past year to transform into the new Pfizer.

Albert Bourla Pfizer 2020 R&D Day

Pfizer (PFE) has a storied history dating back to its founding in 1849. Businesses do not thrive for over 170 years without redefining themselves, which is what Pfizer has done. The latest chapter was written in November when they spun off the Upjohn franchise. This followed the Consumer Health spin out with GlaxoSmithKline (GSK) in 2018 which cleared the way for a New Pfizer era of biopharma innovation.

Pfizer stock has established a base over the past few years while the market cap of $200 billion remained at the 2006 level. Competition-prompted by patent expirations-will have that effect. Remember Lipitor? It provided an average of $11 billion annually in the nine years ended in 2011, contributing 25% of Pfizer revenues. Last year the LDL drug generated a respectable $2 billion-still 20% of Upjohn. How about Viagra? Similar cycle. Same result.

Pfizer is projecting average revenue growth of at least 6% through 2025, though much of that growth is back-end loaded. The good news is that you could generate 10% annually on your investment while you wait for the pipeline to produce these results.

Source: Pfizer Q3 presentation, page 8

Combined yield of 10%: Getting paid to wait.

Investment in Pfizer shares today provides healthy dividend income that we expect will continue to increase.

Albert Bourla 2020 R&D day

The current dividend yield is 4.2% with a ten-year history of growth. Total return investors should consider selling covered calls, which can bring the annual yield to over 10% with minimal risk of having calls assigned. At the time this article was written, a buy-write strategy would result in the following:

  • Buy stock assume $37.
  • Earn next dividend likely $0.40 per share on January 30, 2021.
  • Sell January $41 strike calls for $0.50 premium (my premium Nov 27th).
  • Dividend plus option premium of $0.90 per share is > 10% annualized.

There is some “risk” of the stock rallying 11% to the strike price-a good problem to have. Some investors would roll the option forward. Alternatively, take the profits and wait for an inevitable opportunity to rebuy at a lower price. Pfizer is highly unlikely to run significantly higher in the short term (see chart). The real appreciation opportunity is longer term.

For more see: Dividend Investing With Covered Calls: Why Stop at Yield?

Financial recap: A look back to step forward

As can be seen in the below

Read More
medicine

North America Sports Medicine Market 2020 to Witness Excellent Long-Term Growth Outlook

Pune, New York, USA, November 24 2020 (Wiredrelease) Research Dive :According to a new report published by Research Dive, titled, Sports Medicine Devices Market : North America Opportunity Analysis and Industry Forecast, 2018-2025,the North America sports medicine devices market was valued at $3,580 million in 2018, and is expected to reach $5,382 million by 2025, registering a CAGR of 6.7% from 2019 to 2025.

Sports medicine deals with the physical fitness of athletes. It is used for prevention and treatment of injuries related to sports and exercise. Common sport injuries include anterior cruciate ligament (ACL) tears, ankle sprains, muscle cramps, and shin splints. Sports medicine doctors are trained to restore function to injured patients, so they can get moving again as soon as possible. Demand for sports medicine devices has increased considerably, owing to active participation of athletes in various sports across different countries. Various aspects of sports medicine such as indulging in sports activities for fitness, recommendations for physical training, and sports injury prevention treatment further contribute toward the market growth.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/3

Rise in incidence of sports-related injuries in the young population majorly drives the growth of the sports medicine devices market. Moreover, sports injuries have become highly prevalent among the young population, owing to increase in participation in sports. In addition, increase in initiatives by governments of various countries to promote sports activities and rise in demand for minimally invasive surgeries boost the market growth. Furthermore, easily accessible and advanced treatment products related to sports medicine for quick easy recovery fuel the demand for sports medicine. However, lack of skilled professionals as well as inappropriate administration and guidelines in the field of sports medicine hamper the growth of the market. Conversely, rising influx of athletes and technological advancements in sports medicine are expected to offer remunerative opportunities for the North America sports medicine market players.

The body reconstruction repair segment is anticipated to dominate the market during the forecast period. This is attributed to the fact that body reconstruction repair products are majorly used in the treatment and prevention of sport-related injuries. Among body reconstruction repair products, the bone/cartilage repair reconstruction segment is expected to register the highest CAGR during the forecast period. Considering body support recovery products, the support devices braces segment was the highest revenue contributor in 2018, accounting for five-ninths share. The knee injuries segment is estimated to grow at the highest CAGR from 2018 to 2025, as athletes frequently suffer from such injuries. Sports medicines are principally employed in the treatment of knee injuries, owing to increase in incidence of meniscus tear among sportspersons.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/3

Key Findings of the Sports Medicine Devices Market:

The body support recovery segment is anticipated to generate the second highest revenue during the forecast period.
Artificial joint implants serve to be the highest contributor to the orthopedic sports medicine devices market in 2018 and is expected to maintain this dominance

Read More
medicine

Global Ayurvedic Medicine Market Size by Regional Industry Growth, Statistics & Forecast by 2025

The MarketWatch News Department was not involved in the creation of this content.

Nov 26, 2020 (Market Insight Reports) —
Selbyville, Delaware, MarketStudyReport.com offers report on Global Ayurvedic Medicine Market that evaluates industry growth trends through historical data and estimates prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2020 – 2025.

The global Ayurvedic Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.4% in the forecast period of 2020 to 2025 and will expected to reach 7331.5 million by 2025, from 4754.3 million in 2019.

The Ayurvedic Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Request a sample copy of this report at:

https://www.marketstudyreport.com/request-a-sample/2468922/?utm_source=Marketwatch.com&utm_medium=SK

Main Objectives of this Global Ayurvedic Medicine Marketstudy:

To provide detailed information regarding the major factors (drivers, restraints, opportunities, and challenges) influencing the growth of the Global Ayurvedic Medicine Market.

To strategically analyze the Micro markets with respect to individual growth trends, Prospects, and Contributions to the total market.

To analyze opportunities in the overall Global Ayurvedic Medicine Market for stakeholders by identifying the high growth segments.

To describe and forecast the overall Global Ayurvedic Medicine Market, in terms of value, segmented based on type, and application.

To forecast the market size for various segments, by key region.

The Global Ayurvedic Medicine Market spans across five major geographies: North America, Latin America, Europe, Asia-Pacific and the Middle East and Africa.

To analyze opportunities in the overall Global Ayurvedic Medicine Market for stakeholders by identifying the high growth segments.

To profile key players and analyze their Market ranking in terms of revenues and core competencies and provide details of the competitive landscape for the Global Ayurvedic Medicine Market leaders.

To analyze growth strategies such as Contracts, Mergers and Acquisitions, Product launches and Developments, and Research and Development in the overall Global Ayurvedic Medicine Market.

Segmentation of Global Ayurvedic Medicine Market:

Ayurvedic Medicine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Ayurvedic Medicine market has been segmented into:

Health Care

Oral Care

Hair Care

Skin Care

Others

By Application, Ayurvedic Medicine has been segmented into:

Women

Men

Kids

key Companies covered:

Patanjali Ayurved Limited

Vicco Laboratories

Himalaya Drug

Dabur

Shahnaz Husain Group

Emami Group

Charak Pharma

Baidyanalh

Maharishi Ayurveda

Amrutanjan Healthcare

Botique

Natreon

Herbal Hills

Basic Ayurveda

Main reasons for the purchase:

To obtain insightful analysis of the Global Ayurvedic Medicine Market and a comprehensive understanding of

Read More
medicine

Generic medicine Market Anticipated for Progressive CAGR Growth During 2020-2027

Pune, New York, USA, November 24 2020 (Wiredrelease) Research Dive :Despite of pandemic, the generic medicine market is predicted to grow immensely in the forecast period. Increasing healthcare cost is predicted to be the major driving factor for the market in the forecast period. Oncology therapeutic application will be most lucrative in the estimated period. Vaccine segment is predicted to have the highest market share. North America region is predicted grow enormously in the projected time frame.

Generic medicine market is predicted to grow enormously in terms of revenue in the forecast period. Increasing cases of chronic diseases such as cancer, tuberculosis, diabetes, cardiovascular diseases and many other among the population is predicted to be the major driving factor for the global generic medicine market in the forecast period. Moreover,the treatment cost of these diseases in the healthcare is very high, with the help of generic medicines the treatment cost will be very less which is predicted to boost the global generic medicine market in the forecast period.At present majority of the companies are focusing on treating corona patients with the help of generic drugs which is predicted to be boost the market in the forecast period. For instance, Cipla to sell generic version of Remdesivir for 4,000 to Covid-19 patients. Cipla has developed a generic version of Remdesivir, which would be the lowest-priced COVID drug around the world. Adverse effected associated with the drugs on patients is predicted to hinder the market in the forecast period. In addition, the misconception about the drugs among the population is predicted to hamper the market in the forecast period. During this unpredicted situation, we are helping our clients in understanding the impact of COVID19 on the global social commerce market.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/request-toc-and-sample/122

Our report includes:

Technological Impact
Social Impact
Investment Opportunity Analysis
Pre- Post-COVID Market Scenario
Infrastructure Analysis
Supply Side Demand Side Impact

According to a study conducted by Research Dive, the generic medicine market is expected to register a revenue of $462.1 billion by 2027.

The global market is classified on the basis of type and application. The report offers the complete information about drivers, opportunities, restraints, segmental analysis and major players of the global market.

Factors Affecting the Market Growth

As per our analyst, increasing healthcare cost is predicted to be the major driving factor for the global generic medicine market in the forecast period. Moreover, the misconception about the drugs among the population is predicted to be the biggest restraints for the market in the estimated period.

Vaccine Segment is Predicted to be the Most Lucrative Segment

On the basis of product, the generic medicine market is further classified into blood factors, cytokines, immunoglobulin, insulin, monoclonal antibodies, peptide antibiotics, peptide hormones, vaccines and others. Vaccines segment is predicted to grow enormously in the forecast period. Manufacturing of vaccines are comparatively low as the manufacturing cost is low the price of vaccines will be affordable which is predicted to drive

Read More
medicine

Trigeminal Neuralgia Treatment Medicine Market Analysis, Overview, Growth, Demand and Forecast Research Report to 2026

The MarketWatch News Department was not involved in the creation of this content.

Nov 25, 2020 (The Expresswire) —
The report “Trigeminal Neuralgia Treatment Medicine Market” in Global to 2026 – Market Scope, Development, and Predictions offers the most up-to-date industry information on the actual market situation, and future outlook for vision frames and mountings in worldwide.

The research includes historic data from 2020 and forecasts until 2026 which makes the report a valuable resource for industry executives, presentation, sales and product managers, consultants, analysts, and other people looking for key industry data in a readily available document with clearly presented tables and Figures.

Request a sample copy of the report – https://www.absolutereports.com/enquiry/request-sample/16562110

Trigeminal Neuralgia Treatment Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Trigeminal Neuralgia Treatment Medicine business, the date to enter into the Trigeminal Neuralgia Treatment Medicine market, Trigeminal Neuralgia Treatment Medicine product introduction, recent developments, etc.

The Following Manufacturers Are Covered in This Report:

● Novartis Pharma AG ● Sihuan Pharma ● Wuhan Humanwell ● Raybow Pharma ● Jinan Jinda Pharmaceutical ● Sinopharm ● Jiangsu Tohope Pharma ● Yabang Medicine ● Taro ● Torrent Pharmas ● Wockhardt Bio AG ● Apotex Inc ● Teva Pharmas ● Zydus Pharms ● Unique Pharm ● Rubicon ● Sun Pharma Inds ● Glenmark Pharms Ltd ● Breckenride Pharm ● Amneal Pharms

TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT – REQUEST SAMPLE

Trigeminal Neuralgia Treatment Medicine Market Breakdown Data by Type

● Carbamazepine ● Oxcarbazepine ● Others

Trigeminal Neuralgia Treatment Medicine Market Data by Application

● Hospitals ● Clinic ● Others

Inquire Or Share Your Questions If Any Before The Purchasing This Report – https://www.absolutereports.com/enquiry/pre-order-enquiry/16562110

Geographic Segmentation

The report offers exhaustive assessment of different region-wise and country-wise Breast Localization Needles markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Breast Localization Needles market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.

Detailed TOC of Global Trigeminal Neuralgia Treatment Medicine Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application

1 Trigeminal Neuralgia Treatment Medicine Market Overview

1.1 Product Overview and Scope of Trigeminal Neuralgia Treatment Medicine

1.2 Trigeminal Neuralgia Treatment Medicine Segment by Type

1.2.1 Global Trigeminal Neuralgia

Read More
medicine

Precision Medicine Market Sets 2025 Economic Growth Target with Higher Percent, a Post-COVID 19 Plan

The MarketWatch News Department was not involved in the creation of this content.

According to the 2020 Market Research Future Survey, the analysts saw 12.48% of business growth in the Global Precision Medicine Market 2020 is expected to register. Five months later, in May 2020, as the COVID-19 pandemic spread worldwide, there was less possibility that business was having a favorable impact on a broader note. The analysts further studied that the market can reach a valuation of USD 126.14 Billion by 2025. The entire growth scenario is predicted to take place during the years 2014-2022.

Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @ https://www.marketresearchfuture.com/sample_request/925

Precision Medicine–Boomers & Decliners

The field of precision medicine has made extensive progress with prime discoveries such as microarray/ biochips and single nucleotide polymorphism. These advancements in healthcare have been beneficial for patients to the core of the pharmaceutical industry as well as society. The advent of precision medicine has made researchers understand the method of patients clinical profiles. Human genome research is the future of precision medicine as it owes maximum potential to modify medical treatments for individual patients through the understanding of molecular profiles, genetics, and clinical characteristics in determining the treatment. These factors have made the precision medicine market more robust and stable during the COVID 19 pandemic period.

MRFR’s report presents the factor rising prevalence of cancer to be projected as a booster for personalized cancer diagnostics and therapeutics demands that will leave a positive impact on theprecision medicine market growth. As per a recently published article, in 2018, in the U.S., roughly 1.7 million cases were diagnosed with cancer alone. Apart from this, more factors propelling the growth of this market are escalating online collaborative forums, rising efforts to characterize genes and advancements in cancer biology.

Furthermore, precision medicine applications are chiefly directed toward better treatment against oncological diseases, with an estimated 30% and above market leadership over other segments. According to the data reported in clinicaltrials.gov, the United States and a few European countries are the foremost hubs for conducting and recruiting patient pool for precision medicine applications in oncology globally. The elevated support from the government through funding and rapid growth of genomic analysis might boost the development of the precision medicine market at a fast velocity in the forecast period.

Precision Medicine Market Segment Review

The global precision medicine market has been studied under ecosystem players, sub-markets, and therapeutics.

By the segment of ecosystem players, the global precision medicine market has included diagnostic companies, pharmaceuticals and biotechnology companies, clinical laboratories, and healthcare IT specialists/big data companies. The diagnostic tool companies segment grabbed a market value of USD 16.27 million back in 2017.

By the segment of sub-markets, the market has included molecular diagnostics, companion diagnostics, biomarker-based tests, targeted therapeutics, pharmacogenomics (PGX), and others.

By the segment of therapeutics, the market has included cardiovascular disease (CVD), cancer/oncology, infectious diseases, central nervous system, and others.

Precision Medicine Market Regional Aspect

North America presently

Read More
medicine

Herbal Medicine Market Size 2020 Trends, Research, Development Status, Opportunities, Plans, Competitive Landscape and Growth by Forecast 2026

The MarketWatch News Department was not involved in the creation of this content.

Nov 21, 2020 (The Expresswire) —
“Final Report will add the analysis of the impact of COVID-19 on this industry.”

Global “Herbal Medicine Market” report 2020 gives complete research on market size in the form of value, capacity, production and consumption in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. Players, stakeholders, and other participants in the global Herbal Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on Herbal Medicine industry revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Get Sample Copy of this Report at: https://www.industryresearch.co/enquiry/request-sample/16690445

Herbal Medicine Market Summary: Herbal medicine–also called botanical medicine or phytomedicine refers to using a plant’s seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. Herbalism has a long tradition of use outside of conventional medicine. It is becoming more mainstream as improvements in analysis and quality control along with advances in clinical research show the value of herbal medicine in the treating and preventing disease.

Traditional herbal medicines are naturally occurring, plant-derived substances with minimal or no industrial processing that have been used to treat illness within local or regional healing practices.
In consumption market, Europe and Asia Pacific are the mainly consumption regions due to the bigger demand of downstream applications. In 2017, these two regions occupied 72.36% of the global consumption volume in total.

Market Analysis and Insights: Global Herbal Medicine Market
The global Herbal Medicine market size is projected to reach USD 218940 million by 2026, from USD 148360 million in 2020, at a CAGR of 6.7% during 2021-2026.

This report classifies the global Herbal Medicine industry breakdown information by manufacturers, region, type and application. Additionally, studies the market status, share, rate of growth, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s 5 Forces Analysis of Herbal Medicine Market.

Herbal Medicine research report has combined the analysis of different aspects that increase the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This report also provides the scope of different segments and applications that can potentially influence the market in the future.

To Understand How COVID-19 Impact is Covered in this Herbal Medicine Report Click Here…

Market Segmentation Analysis: The Herbal Medicine research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. by Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the Herbal Medicine market growth.

By Company:

● Tsumura ● Schwabe ● Madaus ● Weleda ● Blackmores ● Arkopharma ● SIDO MUNCUL ● Arizona Natural

Read More
fitness

Interactive Fitness Market 2020-2024- Featuring Axtion Technology LLC, EGYM Inc., among others to contribute to the market growth | Industry Analysis, Market Trends, Opportunities and Forecast 2024

LONDON–(BUSINESS WIRE)–The interactive fitness market is poised to grow by USD 4.81 bn during 2020-2024, progressing at a CAGR of almost 7% during the forecast period.

Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Get FREE Sample Report in Minutes!

The report on the interactive fitness market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the growing awareness among people about fitness and a healthy lifestyle.

The interactive fitness market analysis includes end-user segment and geography landscape. This study identifies the adoption of fitness-related initiatives by corporates as one of the prime reasons driving the interactive fitness market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The interactive fitness market covers the following areas:

Interactive Fitness Market Sizing

Interactive Fitness Market Forecast

Interactive Fitness Market Analysis

Companies Mentioned

  • Axtion Technology LLC
  • Echelon Fitness Multimedia LLC
  • EGYM Inc.
  • Motion Fitness LLC
  • Nautilus Inc.
  • Nexersys Corp.
  • Paradigm Health and Wellness Inc.
  • Peloton Interactive Inc.
  • TECHNOGYM Spa
  • Tonal Systems Inc.

Related Reports on Consumer Discretionary Include:

  • Massage Equipment Market by Product, End-user, Type, and Geography – Forecast and Analysis 2020-2024– The massage equipment market size has the potential to grow by USD 3.27 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get FREE sample report in minutes
  • Water Heater Market by End-user, Distribution Channel, Type, and Geography – Forecast and Analysis 2020-2024– The water heater market size has the potential to grow by USD 2.76 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get FREE sample report in minutes

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market Outlook
  • Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Non-residential – Market size and forecast 2019-2024
  • Residential – Market size and forecast 2019-2024
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2019-2024
  • Europe – Market size and forecast 2019-2024
  • APAC – Market size and forecast 2019-2024
  • South America – Market size and forecast
Read More
medicine

Regenerative Medicine Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

The MarketWatch News Department was not involved in the creation of this content.

Nov 18, 2020 (SUPER MARKET RESEARCH via COMTEX) —
According to IMARC Group’s latest report, titled “Regenerative Medicine Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,”. Looking forward, IMARC Group expects the global regenerative medicine market to continue its strong growth during the next five years.

Regenerative medicine refers to a field of biomedical sciences involved in restoring the structure and function of damaged cells, organs, and tissues. It includes the study of stem cells that are developed in laboratories and then safely inserted into the human body to regenerate damaged bones, cartilage, blood vessels, and organs. Cellular and acellular regenerative medicines are widely adopted in various clinical therapeutic procedures, including cell therapies, immunomodulation, and tissue engineering. They have the potential to treat various chronic diseases, including Alzheimer’s, Parkinson’s, cardiovascular disorders (CVDs), osteoporosis, spinal cord injuries, etc.

Request For the free Sample Copy of the Report:

https://www.imarcgroup.com/regenerative-medicine-market/requestsample

Market Trends

The rising prevalence of chronic diseases and genetic disorders is primarily driving the demand for regenerative medicine across the globe. Moreover, the growing geriatric population who are more prone to musculoskeletal, dermatological, and cardiological disorders is also augmenting the need for regenerative medicines. Furthermore, several technological advancements in cell-based therapies have led to the adoption of 3D bioprinting techniques and artificial intelligence (AI), thereby further propelling the market for regenerative medicine. Moreover, regenerative medicine decreases the risk of organ rejection by the body post-transplant and increases the patient’s recovery speed, thereby gaining traction in numerous organ transplantation procedures. The increasing investments in extensive R&D activities in the field of medical sciences are expected to drive the market for regenerative medicine.

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Allergan PLC (AbbVie Inc.)
  • Amgen Inc.
  • Baxter International Inc.
  • BD (Becton, Dickinson and Company)
  • Integra Lifesciences Holdings Corporation
  • Medtronic plc
  • Mimedx Group Inc.
  • Novartis AG
  • Osiris Therapeutics Inc. (Smith & Nephew plc)
  • Thermo Fisher Scientific Inc.

The report has segmented the market on the basis of type, application, end user and region.

Breakup by Type:

  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering
  • Others

Breakup by Application:

  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Dermatology
  • Cardiovascular
  • Central Nervous System
  • Others

Breakup by End User:

  • Hospitals
  • Specialty Clinics
  • Others

Explore Full Content of the Report

https://www.imarcgroup.com/regenerative-medicine-market

Breakup by Region:

  • North America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
  • Middle East and Africa

Key highlights of the Report

  • Market Performance (2014-2019)
  • Market Outlook (2020- 2025)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Browse Related Report

https://www.imarcgroup.com/orphan-drugs-market

https://www.imarcgroup.com/acne-drugs-market

Read More